These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation]. Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063 [TBL] [Abstract][Full Text] [Related]
4. The in vitro association of antihemophilic factor and von Willebrand factor. Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497 [No Abstract] [Full Text] [Related]
5. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation]. Schwick HG; Trobisch H; Heimburger N Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663 [No Abstract] [Full Text] [Related]
17. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions]. Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351 [No Abstract] [Full Text] [Related]
18. [Biological diagnosis of von Willebrand's disease (author's transl)]. Castillo R; Maragall S; Liendo F; Ordinas A Sangre (Barc); 1978; 23(5B):728-45. PubMed ID: 310168 [No Abstract] [Full Text] [Related]
19. Influence of high ionic strength buffers on factor VIII/von Willebrand factor from different species. Lavergne JM; Meyer D; Jenkins CS; Obert B; Larrieu MJ Thromb Res; 1978 Sep; 13(3):409-18. PubMed ID: 311086 [No Abstract] [Full Text] [Related]
20. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life]. Duvina PL; Simoni MR; Pezzati M; Poggi G; Rosati C; Trampi F; Duvina G Minerva Pediatr; 1987 May; 39(10):421-36. PubMed ID: 3116376 [No Abstract] [Full Text] [Related] [Next] [New Search]